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Mass spectrometry analysis of protein-nucleic acid cross-links is challenging due to the
dramatically different chemical properties of the two components. Identifying specific sites of
attachment between proteins and nucleic acids requires methods that enable sequencing of
both the peptide and oligonucleotide component of the heteroconjugate cross-link. While
collision-induced dissociation (CID) has previously been used for sequencing such heterocon-
jugates, CID generates fragmentation along the phosphodiester backbone of the oligonucleo-
tide preferentially. The result is a reduction in peptide fragmentation within the heteroconju-
gate. In this work, we have examined the effectiveness of electron capture dissociation (ECD)
and electron-transfer dissociation (ETD) for sequencing heteroconjugates. Both methods were
found to yield preferential fragmentation of the peptide component of a peptide:oligonucle-
otide heteroconjugate, with minimal differences in sequence coverage between these two
electron-induced dissociation methods. Sequence coverage was found to increase with
increasing charge state of the heteroconjugate, but decreases with increasing size of the
oligonucleotide component. To overcome potential intermolecular interactions between the two
components of the heteroconjugate, supplemental activation with ETD was explored. The addition
of a supplemental activation step was found to increase peptide sequence coverage over ETD
alone, suggesting that electrostatic interactions between the peptide and oligonucleotide
components are one limiting factor in sequence coverage by these two approaches. These
results show that ECD/ETD methods can be used for the tandem mass spectrometry
sequencing of peptide:oligonucleotide heteroconjugates, and these methods are comple-
mentary to existing CID methods already used for sequencing of protein-nucleic acid
cross-links. (J Am Soc Mass Spectrom 2010, 21, 1387–1397) © 2010 Published by Elsevier
Inc. on behalf of American Society for Mass SpectrometryProtein-nucleic acid complexes have many diversefunctions in cellular events such as pre-mRNAprocessing [1], RNA transcription [2], protein
transportation [3], tRNA maturation [4], miRNA-based
translational control [5], viral replication [6], and pro-
tein translation [7]. A traditional biochemical approach
for the detailed structural analysis of protein-nucleic
acid complexes has involved the use of cross-linking.
Cross-linking studies provide information about spe-
cific interactions among the components of such com-
plexes. An overriding characteristic of cross-linking
studies has been the difficulties in elucidating specific
protein and nucleic acid sites of interaction using con-
ventional analytical or biochemical approaches [8].
Mass spectrometry has become a useful analytical
approach for characterizing protein-nucleic acid cross-
linked complexes [8, 9]. Urlaub and coworkers have
demonstrated the utility of mass spectrometry methods
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tion of small nuclear ribonucleoprotein (snRNP) com-
plexes reconstituted in vitro and U1 snRNP complexes
purified from HeLa cells [9–13]. Early work by this
group utilized Edman degradation combined with
matrix-assisted laser desorption/ionization mass spec-
trometry (MALDI-MS) to identify cross-linking sites on
the protein component of the RNP complex [14, 15].
Another method for identification of cross-links took
advantage of the oligonucleotide 3= terminal phosphate
that results after nuclease digestion of the cross-link
[11]. Samples were digested by trypsin and divided in
two, with one portion analyzed directly by MALDI-MS,
and the second portion subjected to an additional
alkaline phosphatase digestion step to remove any
terminal phosphates before analysis by MALDI-MS.
Cross-linked species were then identified by a mass
shift of 79 Da between the two samples.
More recently, liquid chromatography-mass spec-
trometry (LC-MS) methods have been developed for the
characterization of protein-nucleic acid cross-links. One
such development was the use of multiple reaction
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of a phosphoric acid group (HPO3, 80 Da), which
serves as a signature for peptide:oligonucleotide cross-
links present in a mixture of peptides [13]. Ions detected
by this MRM approach could be mapped onto the
original complex by manually going through all possi-
ble combinations of tryptic peptides and digested nu-
cleotides that could result in the MRM identified mass.
Yet another method utilized the unique mass defect of
peptide:oligonucleotide cross-links to differentiate be-
tween peptides and cross-links [16]. Because peptides
contain a relatively high percentage of elements with a
positive mass defect (e.g., N and H) while oligonucleo-
tides contain oxygen and phosphorus, which have
negative mass defects, the use of high-resolution mass
spectrometry, during LC-MS, allows one to identify
mass defect values that are indicative of peptide:oligo-
nucleotide cross-links.
In addition to methods that can be used to identify
the presence of peptide:oligonucleotide cross-links
within complex samples, Urlaub and coworkers have
also developed purification methods compatible with
downstream sequencing of such heteroconjugates [10].
Cross-links were first purified by an online 2-D nanoLC
system integrated with TiO2 affinity purification. Puri-
fied cross-links were then identified using MALDI-MS
and sequenced by either collision-induced dissociation
(CID) on a tandem time-of-flight (TOF/TOF) [10] in-
strument or by post-source decay [12].
While those studies nicely illustrate the application
of mass spectrometry for such structural studies, the
sequence characterization of protein-nucleic acid com-
plexes, usually as peptide:oligonucleotide cross-linked
heteroconjugates, present a unique challenge to mass
spectrometry because peptides and oligonucleotides
prefer opposite ionization modes [17]. Jensen et al. first
described the challenges of analyzing such heterocon-
jugates, and provided suggested instrumental condi-
tions, spray solutions, and matrices that would be
effective for either electrospray ionization (ESI) or
MALDI mass spectrometry of heteroconjugates.
In addition to ionization challenges, mass spectrometry-
based sequencing of heteroconjugates also presents difficul-
ties arising from the different chemical properties of the
oligonucleotide and peptide components. Most heteroconju-
gate sequencing by mass spectrometry is performed using
CID as the method of fragmentation, where bond lability
influences the fragmentation pathway [18, 19]. CID of
peptide:oligonucleotide heteroconjugates produces more
bond cleavages from the phosphodiester backbone of the
oligonucleotide than from the peptide backbone [17]. Conse-
quently, while CID (in particular, as implemented in LC-
MS/MS) is useful for identifying the sequence of the cross-
linked oligonucleotide, along with the site of attachment in
favorable cases, it is far less effective at reporting similar
information for the peptide component. To overcome such
limitations, most applications of CID of heteroconjugates
require that the oligonucleotide component be minimized
[11, 13, 20, 21].Electron capture dissociation (ECD) and electron-
transfer dissociation (ETD) are fragmentation meth-
ods in mass spectrometry that are complementary to
CID methods for peptide and protein sequencing
[22–25]. Unlike CID, in ECD and ETD bond strength
does not dictate sites of fragmentation [26]. Although
the exact mechanism is still subject to some debate,
ECD and ETD fragmentation of peptides yields c and
z series ions instead of b and y series ions as in CID
[24, 25, 27].
Of particular interest here, these electron-based disso-
ciation methods have been more effective at identifying
sites of labile post-translational modifications, such as
phosphorylations in proteins and peptides, than CID-
based approaches [28, 29]. Because peptide:oligonucle-
otide heteroconjugates can be viewed, simplistically, as
peptides containing a labile modification (an oligonucleo-
tide), we were interested in determining how effective
ECD and/or ETD would be at generating fragmentation
along the peptide backbone of a peptide:oligonucleotide
heteroconjugate. Further, the effects of heteroconjugate
charge state and size on ECD and ETD fragmentation
were explored. We find that ECD and ETD can yield
peptide fragmentation, useful for identifying sites of cross-
link attachment on the peptide, and these sequencing
approaches are complementary to CID-based sequencing
of heteroconjugates. As with CID-based approaches, as
the length of the oligonucleotide component increases, the
reduction in cross-link charge state and/or intermolecular
interactions between the peptide and oligonucleotide limit
fragmentation efficiency. Supplemental activation during
ETD was found to increase peptide fragmentation, sug-
gesting that intermolecular interactions between the two
components are one limiting factor in ECD and ETD
efficiency.
Materials and Methods
Materials
The peptide, (Ac-GARGADRAVLARRR-NH2), was
purchased from Biomer Technology (Hayward, CA,
USA), and was synthesized with an acetylated N-
terminus and an amidated C-terminus to avoid cross-
linking at undesired points. A dinucleotide 5=-pCpU-3=
was obtained from Dharmacon RNAi Technologies
(Lafayette, CO, USA) with a 6-carbon amino-linker on the
5= phosphate group. Peptide-oligonucleotide heteroconju-
gate 2 (HC2), with the dinucleotide coupled to the carbo-
xylic acid of the aspartic acid residue on the peptide via
the amino-linker, was provided by Biomer Technology
using the peptide and dinucleotide as starting materials.
Peptide-oligonucleotide heteroconjugate 1 (HC1) was
generated from HC2 by digestion with one unit of
snake venom phosphodiesterase (SVP, Worthington
Biochemical Corp., Lakewood, NJ, USA) at pH 10 for
48 h. Complete digestion of the terminal uridine was
confirmed by MALDI-MS.
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Tedia Company Inc. (Fairfield, OH, USA) or Honeywell
Burdick and Jackson (Muskegon, MI, USA). Triethyl-
amine and formic acid were purchased from Fisher
Scientific (Pittsburg, PA, USA), and ammonium acetate
was purchased from EMD (Gibbstown, NY, USA).
Heteroconjugate Purification
HC2 was purified by HPLC to remove unreacted pep-
tide and oligonucleotide. A Hitachi LaChrome Elite
HPLC (Hitachi, San Jose, CA, USA) with a L2130
pump/controller and L-2455 diode array detector was
used. The column used was a 5 m 4.6 mm  250 mm
Supelcosil LC-18 column (Sigma-Aldrich, St. Louis,
MO, USA). Buffer A was 5 mM ammonium acetate with
0.1% formic acid, and Buffer B was 100% acetonitrile
with 0.1% formic acid. A linear gradient was used from
1% B to 90% B over 50 min. One-minute fractions were
collected, taken to dryness and resuspended with 50%
aqueous acetonitrile, 5 mM ammonium acetate, and
0.1% formic acid. The fraction containing the cross-link
was identified by MALDI-MS, and then stored at
80 °C before analysis.
To purify HC1 from the enzymatic digestion of HC2,
the digestion mixture was loaded on a 50,000 Da
molecular weight cut-off filter from Amicon (Millipore,
Billerica, MA, USA) to remove SVP. The sample was
then desalted with Millipore C18 Zip-Tips and stored at
0 °C before analysis.
Mass Spectrometry
All MALDI-TOFMS analyses were performed on a
Bruker (Billerica, MA, USA) Reflex IV equipped with a
nitrogen laser and operated in positive polarity, reflec-
tron mode. Matrix was prepared using a saturated
solution of 2,4,6-trihydroxyacetophenone in 50 mM
diammonium hydrogen citrate/50% aqueous acetoni-
trile. Approximately 1 L of sample was combined with
5 L of matrix and spotted on a MTP 384 Massive target
plate and allowed to dry.
All ECD and CID experiments were performed in
positive polarity on a Thermo (Waltham, MA, USA)
LTQ-FTMS. Samples were diluted into a buffer of 50%
aqueous acetonitrile, 5 mM ammonium acetate and
0.1% formic acid then loaded into PicoTip (New Objec-
tive, Woodburn, MA, USA) 2  1 m emitters for static
nanospray. The general parameters used at the spray
interface were a capillary voltage of 35 V, capillary
temperature of 275 °C and a tube lens of 110 V. ECD
energies were varied from 0 to 20 in arbitrary units
(a.u.) with durations ranging from 7 to 120 ms. A
normalized collision energy of 20%–50% was used for
CID experiments. The tip voltage was typically 1.5 kV
and isolation widths were typically 2–-5 m/z units. All
samples, peptides and heteroconjugates, were subjected
to the same CID and ECD conditions to facilitate
comparisons of fragmentation.All ETD experiments were performed in positive
polarity on a Thermo LTQ-XL using fluoranthene as the
anion reagent. Samples were diluted into a buffer of
50% aqueous acetonitrile, 5 mM ammonium acetate and
0.1% formic acid then loaded into PicoTip 2  1 m
emitters for static nanospray. The general parameters
used at the spray interface were a capillary voltage of
30–40 V, capillary temperature of 200 °C, and a tube
lens of 100–200 V. ETD durations were varied from
0–200 ms, which were obtained by automatic optimiza-
tion on a known ETD fragment. The tip voltage was
typically 1.5 kV and isolation widths were typically 2–5
m/z units. Default supplemental activation (SA) condi-
tions were used for all ETD-SA experiments.
Results and Discussion
ECD and ETD are effective dissociation approaches for
localizing sites of phosphorylation in peptide sequences
[29, 30]. Because peptide phosphorylation can be
viewed as a simplistic example of a peptide:oligonucle-
otide heteroconjugate, the effectiveness of ECD and
ETD for heteroconjugate sequence analysis was exam-
ined. Two heteroconjugates (Table 1) were used to
assess the effects of charge state and length of the
oligonucleotide on ECD and ETD efficiency. Results
obtained using ECD and ETD were also compared with
dissociation of these heteroconjugates using CID.
Before evaluating the effectiveness of ECD and ETD
at sequencing heteroconjugates, the 14 amino acid pep-
tide (Ac-GARGADRAVLARRR-NH2), without a conju-
gated mono- or dinucleotide, was characterized by CID,
ECD and ETD (Supplemental Figure S1, which can be
found in the electronic version of this article). This
peptide was used as a model system because it allowed
for a direct comparison to previous results obtained by
Jensen et al. on this peptide and subsequent peptide:
oligonucleotide heteroconjugates [17]. Fragmentation of
the 3 charge state (the most abundant charge state)
resulted in 12 out of 26 expected b and y series ions for
CID (Supplemental Figure S1a), 23 out of 26 expected c
and z series ions for ECD (Supplemental Figure S1b),
and 17 out of 26 expected c and z series ions for ETD
(Supplemental Figure S1c). These fragmentation data
serve as the reference point to compare whether disso-
ciation of a heteroconjugate is comparable to dissocia-
tion of the peptide alone.
Table 1. Peptide-oligonucleotide heteroconjugates (HC)
investigated in this study
Abbreviation Sequence
Heteroconjugate
1 (HC1)
Ac-GARGAD(NH(CH2)6pC)RAVLARRR-NH2
Heteroconjugate Ac-GARGAD(NH(CH2)6pCpU)RAVLARRR-
2 (HC2) NH2
1390 KRIVOS AND LIMBACH J Am Soc Mass Spectrom 2010, 21, 1387–1397CID, ECD, and ETD of HC1
HC1 is a heteroconjugate comprised of a 14 amino acid
peptide containing 5 arginine residues covalently
linked through an internal aspartic acid residue to a
single cytidine 5=-monophosphate. The ESI mass spec-
trum of HC1 (Supplemental Figure S2a) shows a charge
distribution that favors the 3 charge state with an
appreciable fraction in the 2 and 4 charge states.
CID of the 3 charge state only yields one d series
nucleotide fragment with no major fragment ions that
can be assigned to the peptide backbone (Supplemental
Figure S2b). Figure 1 a and b are representative data
obtained from ECD and ETD of the 3 charge state,
respectively. ECD generates 21 out of 26 expected c and
z series peptide backbone fragments, one d series nu-
cleotide fragment at two charge states, and one arginine
side-chain loss (Figure 1a). ETD produces 19 out of 26
expected c and z series peptide backbone fragments
(Figure 1b). The sequence coverage from ECD is suffi-
cient to localize the cytidine 5=-monophosphate site of
attachment to the aspartic acid residue, while ETD
results are sufficient to localize it to one of two amino
acids in the peptide sequence. Thus, ECD and ETD
fragmentation of HC1 provides essentially identical
sequence coverage as ECD and ETD fragmentation of
the peptide component lacking the aminohexyl-linked
mononucleotide.
Similar results were obtained from CID, ECD and
ETD fragmentation of the 4 charge state of HC1. CID
of HC1 (Supplemental Figure S3a) yields fragmentation
localized to the cytidine phosphodiester group with no
fragmentation detected along the peptide backbone. In
contrast, both ECD (Supplemental Figure S3b) and ETD
(Supplemental Figure S3c) yield significant fragmenta-
tion along the peptide backbone. ECD provides 22 out
of 26 expected c and z series ions from the peptide
backbone and one d series ion arising from the cytidine
phosphodiester group. Similarly, ETD provides 21 out
of 26 expected c and z series ions from the peptide
backbone. This level of sequence coverage from both
ECD and ETD is sufficient to localize the attachment
site to the aspartic acid residue.
Although the 2 charge state for HC1 was generated
at a significantly lower abundance than the 3 charge
state, CID, ECD and ETD characterization of this charge
state was also attempted resulting in only minor se-
quence coverage of the peptide backbone. Again, CID
results in fragmentation only at the cytidine phosphodi-
ester group (Supplemental Figure S4a). ECD yielded 4
out of 26 expected c and z series ions from the peptide
backbone (Supplemental Figure S4b). The ETD results
from the 2 charge state of HC1 are discussed in a later
section.
Sequence characterization of the 4 charge state of
HC1 is enhanced by the larger electron capture cross-
section, which leads to a relatively high signal-to-noise
ratio for fragment ions generated by ECD or ETD. The
only significant drawback to working with a highlycharged precursor is that the product ions have charge
states ranging from 1 to 3, which can hinder se-
quence assignments in cases where the charge state
cannot be unambiguously determined. As the 3
charge state was generated at a similar, albeit slightly
higher, abundance as the 4 charge state, the signal-to-
noise ratios of product ions from dissociation of the 3
charge state were generally sufficient for routine assign-
ment with product ion charge states detected at both 1
and 2.
CID, ECD, and ETD of HC2
The results obtained from HC1 suggest that ECD and
ETD are potentially effective dissociation methods for
generating peptide backbone cleavages that would per-
mit the localization of a site of cross-linking within
a peptide:oligonucleotide heteroconjugate. Moreover,
ECD and ETD were both found to be significantly better
than CID, which did not yield any appreciable peptide
backbone fragment ions. However, HC1 contained only
a simple mononucleotide covalently attached to the
peptide through the aminohexyl-linker. To determine
whether the addition of another nucleotide group
would affect ECD and ETD fragmentation of the back-
bone, a second heteroconjugate, HC2, was analyzed.
The only difference between HC1 and HC2 is an
additional uridine 5=-monophosphate onto the 3=-end of
the cytidine, creating a dinucleotide covalently attached
to the peptide through the aminohexyl-linkage at the
internal aspartic acid.
The ESI mass spectrum of HC2 is seen in Supple-
mental Figure S5a and shows a charge distribution that
favors the 3 charge state with an appreciable fraction
in the 4 charge state. CID of HC2 generates two d
series fragments from the dinucleotide and no assign-
able peptide backbone fragment ions (Supplemental
Figure S5b). Figure 2a and b are representative data
obtained from ECD and ETD of the 3 charge state,
respectively. ECD yielded 10 out of 26 expected c and z
series ions from the peptide backbone, and one d series
fragment from the dinucleotide (Figure 2a). ETD was
discovered to be slightly more effective than ECD, as 13
out of 26 expected c and z series ions from the peptide
backbone were detected (Figure 2b). Neither ECD nor
ETD of the 3 charge state generated sufficient peptide
backbone sequence coverage to uniquely locate the site
of dinucleotide linkage, although both approaches
could minimize the potential sites of cross-linking and
both approaches were significantly more effective at
characterizing the peptide component than was CID.
More peptide backbone cleavages were obtained
from ECD and ETD fragmentation of the 4 charge
state, as compared to the more abundant 3 charge
state, of HC2. CID of the 4 charge state of HC2
generates only fragmentation along the dinucleotide
backbone (Supplemental Figure S6a). ECD yielded 11
out of 26 expected c and z series ions from the peptide
backbone (Supplemental Figure S6b). ETD yielded the
ence
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26 expected c and z series ions from the peptide
backbone detected (Supplemental Figure S6c). The ETD
results are sufficient to identify the amino acid with the
Figure 1. (a) ECD and (b) ETD tandem mass sp
were: collision energy of 10 (a.u.) and duration
were: duration of 132 ms with 67 summed scan
spectra and mapped to the heteroconjugate sequaminohexyl linker.CID, ECD, and ETD characterization of the low
abundance 2 charge state was also attempted, al-
though essentially no fragmentation of the peptide
backbone resulted (Supplemental Figure S7). As with
of the 3 charge state for HC1. ECD parameters
ms with 120 summed scans. ETD parameters
ntified fragment ions are denoted on the mass
.ectra
of 70
s. Idethe 3 and 4 charge states, CID of the 2 charge state
ence
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otide (Supplemental Figure S7a). ECD of the 2 charge
state yielded only the z11
 ion that could be assigned to
peptide fragmentation (Supplemental Figure S7b). In
the case of ETD of the 2 charge state, no peptide or
dinucleotide fragment ions were detected (Supplemen-
Figure 2. (a) ECD and (b) ETD tandem mass sp
were: collision energy of 10 (a.u.) and duration
were: duration of 54 ms with 103 summed scan
spectra and mapped to the heteroconjugate sequtal Figure S7c).Effect of Charge State on Heteroconjugate
Fragmentation
The charge state of peptide ion being investigated by
ECD and ETD has been shown to play an important role
in the efficiency of capturing electrons, with the prob-
of the 3 charge state for HC2. ECD parameters
ms with 170 summed scans. ETD parameters
ntified fragment ions are denoted on the mass
.ectra
of 70
s. Ideability of electron capture proportional to the square of
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observed here with heteroconjugates HC1 and HC2.
Table 2 summarizes the number of peptide fragment
ions detected for both heteroconjugates at the 2, 3,
and 4 charge states along with the precursor ion
abundance. For both heteroconjugates, minimal peptide
fragment ions were detected at the 2 charge state. For
HC1 the 3 and 4 charge states yielded comparable
numbers of peptide fragment ions. Similarly, for HC2
the 3 and 4 charge states yielded comparable num-
bers of peptide fragment ions, except in the case of ETD
of HC2 at the 4 charge state. ETD fragmentation at the
4 charge state for HC2 was more extensive than at the
3 charge state, with the number of peptide fragment
ions detected being comparable to that found from ECD
and ETD of HC1 at the 3 and 4 charge states.
No differences in peptide fragmentation that could
be attributed to precursor ion abundance could be
discerned from these experiments. Product ion abun-
dances are similar for both heteroconjugates at all
charge states between the two fragmentation tech-
niques (ECD and ETD) indicating that the sensitivities
of ECD and ETD for heteroconjugate sequencing are
comparable. There are differences in product ion abun-
dances when comparing the two heteroconjugates
against each other. HC1 yields fragment ions that are 5
to 20-fold more abundant than fragment ions generated
from HC2. Such differences may be due to the addi-
tional nucleotide residue present in HC2 as discussed
further below.
To determine whether there are any differences in
the sites of fragmentation of the peptide backbone
during ECD and ETD of differing charge states, Figure
3 summarizes the results for Table 2 mapped on the
heteroconjugate sequence. For HC1, the sites of frag-
mentation are consistent between the 3 and 4 charge
states in both ECD and ETD (Figure 3a and b). Peptide
bond fragmentation occurs on both the N- and C-
terminal regions of the peptide with fragmentation
being reduced around the aspartic acid residue where
the aminohexyl cross-linker is attached. For HC2 there
is still a clear preference for peptide fragmentation near
the N- and C-terminal regions, although this localiza-
tion of fragmentation is more pronounced for ECD
(Figure 3c) than ETD (Figure 3d). Both ECD and ETD
result in fewer peptide fragments arising from the
C-terminal side of the cross-link, signifying the possi-
bility that there may be some secondary interactions
Table 2. The number of peptide fragments out of the total poss
charge states for ECD and ETD along with the normalized intens
2
ECD ETD ETD SA ECD
HC1 4/26 2/26 11/26 21/26
8.0E04 2.3E04 2.0E04 4.5E06
HC2 1/26 0/26 6/26 10/26
1.7E05 1.0E04 1.0E04 6.5E05 3.between this positively charged region of the peptide
(due to the three arginine residues) and the dinucle-
otide cross-link.
ETD of Heteroconjugates with Supplemental
Activation
Although HC1 and HC2 showed an increase in the
number of peptide fragment ions with an increase in
charge state, at the 2 and 3 charge states, HC1
yielded more peptide fragments than HC2 when
analyzed at the same charge state even though the
only difference between these two heteroconjugates
is an additional uridine nucleotide on HC2. One
explanation for this difference could be that the
dinucleotide serves as a more effective radical trap
than the mononucleotide, thereby limiting these
radical-driven fragmentation reactions [31]. Another of
the possible explanations for this trend could be an
increase in noncovalent interactions between the dinu-
cleotide and peptide present in HC2 over the mononu-
cleotide and same peptide present in HC1. Creese et al.
previously showed that multiple phosphorylations
lead to an increase in secondary interactions between
the phosphate group and peptide for phosphopep-
tides, with these secondary interactions reducing
ECD fragmentation [32].
Thus, additional experiments were attempted using
supplemental activation with ETD (ETD-SA) in an
attempt to increase peptide fragmentation for these two
heteroconjugates. Figure 4 presents representative spec-
tra from ETD and ETD-SA experiments on HC1 at the
2 charge state. ETD of this charge state results in only
2 out of 26 expected c and z series ions from the peptide
backbone (Figure 4a). In contrast, ETD-SA of the 2
charge state generates 11 out of the 26 expected frag-
ment ions with sequence coverage sufficient to localize
the site of attachment to a three amino acid region of the
peptide (Figure 4b). Thus, ETD-SA analysis of the
heteroconjugates was expanded to all charge states of
HC1 and HC2.
As seen in Table 2, for all charge states investigated
(2, 3, and 4), ETD-SA yielded a greater number of
peptide fragments as compared to ETD alone for both
HC1 and HC2. Interestingly, when the fragmentation
results for the 2 and 3 charge states are mapped on
the peptide sequence (Figure 3e–h), several trends in
ragments for each of the three cross-links at their available
of the precursor ion
3 4
ETD ETD SA ECD ETD ETD SA
9/26 20/26 22/26 21/26 23/26
0E04 8.0E05 2.0E06 6.0E05 6.0E05
3/26 17/26 11/26 22/26 24/26ible f
ities
1
8.
1
5E05 3.5E05 1.0E05 1.5E04 1.5E04
1394 KRIVOS AND LIMBACH J Am Soc Mass Spectrom 2010, 21, 1387–1397Figure 3. Sequence map of (a) ECD and (b) ETD c- and z-series peptide fragments of HC1 at the 2,
3, and 4 charge states. Sequence map of (c) ECD and (d) ETD c- and z-series peptide fragments of
HC2 at the 2, 3, and 4 charge states. Sequence map comparison of ETD and ETD-SA c- and
z-series peptide fragments of HC1 at the (e) 2 and (f) 3 charge states. Sequence map comparison
of ETD and ETD-SA c- and z-series peptide fragments of HC2 at the (g) 2 and (h) 3 charge states.
(i) Structure of HC2 (with HC1 arising from the loss of the uridine nucleotide). Comparative data of
ETD and ETD-SA for the 4 charge states of HC1 and HC2 are not shown due to minimal differences
in the number of peptide fragment ions detected. For all figures, c-series fragment ions are shown to
the bottom of the peptide sequence; z-series fragment ions are shown to the top of the peptide
sequence; and, when detected, nucleotide fragment ions are shown.
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are noticed. The use of supplemental activation for both
heteroconjugates generates significant peptide frag-
mentation on the N-terminal side of the site of attach-
ment, which is also the N-terminal region of the pep-
tide. These data are consistent with the results shown in
Figure 3a–d, where more significant fragmentation
Figure 4. (a) ETD and (b) ETD-SA fragmentati
were performed for 200 ms and 20 scans were su
ions are identified and mapped to the heter
fragmentation when adding supplemental activa
was analyzed.occurs on the N-terminal region of the peptide for ECDand ETD at the various charge states investigated. In
addition, an increase in peptide fragmentation on the
C-terminal side of the site of attachment is found, with
more significant increases noted for the 2 charge
states of both heteroconjugates. Consistent with the
discussion above, secondary interactions through salt
bridges between the phosphodiester group and the
HC1 at the 2 charge state. ETD and ETD-SA
d to generate the mass spectra shown. Fragment
jugate sequence. Similar increases in peptide
ere found at other charge states and when HC2on of
mme
ocon
tion wpositively-charged arginine residues may limit peptide
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(Figure 3i). Supplemental activation may, therefore,
disrupt such interactions leading to the increase in
peptide fragmentation in this region. Finally, the effect
of supplemental activation is less pronounced for HC2
(the dinucleotide) than HC1 (the mononucleotide),
which may also reflect additional sites of secondary
interaction between the two components. Alternatively,
electrostatic attraction between the positively charged
C-terminus and the nucleotide component may allow
the nucleotide component to serve as a radical trap
inhibiting fragmentation along this region, with the
dinucleotide serving as a stronger radical trap than the
mononucleotide. While these data demonstrate supple-
mental activation increases peptide fragmentation for
both heteroconjugates, additional experiments are re-
quired to differentiate between the possible explana-
tions for such an increase.
Comparison with Prior Heteroconjugate
Sequencing Results
Urlaub and coworkers have demonstrated the capabil-
ities of several mass spectrometry methods for sequenc-
ing peptide:oligonucleotide heteroconjugates. Using
post-source decay with MALDI-TOFMS, they character-
ized several cross-links containing large peptides (11 to
23 amino acids) cross-linked to dinucleotides [12]. The
site of attachment on the peptide was identified for one
cross-link, and for two others the site was localized to
one of two amino acids. They also noted that for larger
oligonucleotides components in a cross-link, such as a
5-mer oligonucleotides attached to an 11 amino acid
residue peptide, only the oligonucleotide portion could
be sequenced by post-source decay.
In other data obtained using a Q-TRAP platform, they
found that MS/MS could be used to localize the region of
attachment between oligonucleotide and peptide cross-
links, although the precise sites of attachment could not be
determined [13]. Similarly, when using MALDI-TOF/
TOF as the mass spectrometry platform, they again could
localize the region of cross-linking on the peptide compo-
nent of the cross-link, with complete sequence coverage of
the dinucleotide or trinucleotide component [10]. Therefore,
the possibility exists that the CID conditions in the linear ion
trap used in this study are less effective at generating
fragmentation of the peptide component of these hetero-
conjugates. Whether instrumental differences account for
the limitations of CID or there are unique factors arising
from the cross-linker and/or heteroconjugate sequence
will require further investigation.
Conclusions
The electron-induced dissociation methods ECD and
ETD have been shown to be effective at generating
fragmentation along the peptide component of a
peptide-oligonucleotide heteroconjugate. In contrastto CID, which only generates fragmentation along the
phosphodiester backbone of the oligonucleotide com-
ponent, ECD and ETD generate peptide fragments
that can be used to localize and/or identify sites of
cross-linking to an oligonucleotide. Not surprisingly,
peptide sequence coverage increases with increasing
charge state of the heteroconjugate, with a 3 charge
state being the minimal charge state for sufficient se-
quence coverage to localize a site of cross-linking.
Somewhat surprisingly, the addition of a single
nucleotide to the oligonucleotide component of a het-
eroconjugate significantly reduced the number and
abundance of peptide fragmentation when all other
factors were equal. Thus, the possibility exists that the
length of the oligonucleotide component may lead to
increased non-covalent interactions between the pep-
tide and oligonucleotide within the heteroconjugate.
ETD-SA was shown to improve peptide fragmentation,
particularly for lower charge state ions of a heterocon-
jugate having a longer oligonucleotide component. Al-
though the present study was conducted using nanos-
pray MS, ETD sequencing of heteroconjugates should
be compatible with on-line LC-MS/MS analysis [33].
Based on these studies, several predictions regarding
radical-driven fragmentation of peptide:oligonucleo-
tide heteroconjugates can be made and tested. The
acidic character of the oligonucleotide will inherently
reduce the overall charge state of the heteroconjugate,
which will prove challenging to these dissociation
methods that benefit from more positively charged
ions. Thus, compromises in the overall length of the
oligonucleotide component may be necessary to ensure
heteroconjugates are formed at the 3 charge state, as a
minimum, as this charge state was found to yield
significantly greater numbers of peptide fragment
ions than the 2 charge state heteroconjugates. In
addition, supplemental activation techniques for both
ECD and ETD will be preferred to minimize second-
ary interactions (e.g., salt bridges) between the pep-
tide and oligonucleotide components. Studies are
currently underway to further clarify the role of the
oligonucleotide and its secondary interactions with
the peptide in the heteroconjugate during sequencing
by ECD and ETD. Finally, for this particular model
compound, the presence of a nonpolar methylene
cross-linking reagent may also reduce fragmentation
around the site of attachment to the peptide [34].
Thus, the type of cross-linking reagent may also affect the
sequence coverage one can obtain from peptide:oligo-
nucleotide heteroconjugates. Further studies comparing
different cross-linking reagents, such as 4-thiouridine,
2-iminothiolane and platinum-based compounds are in
progress.
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